


To provide long term capital growth.
| Name | % Net Assets |
|---|---|
| Novartis AG | 3.9% |
| Roche Holding AG Part. Cert. | 3.4% |
| Banco Santander S.A. | 3.2% |
| E.ON AG | 3.2% |
| France Telecom | 3.2% |
| Bayer AG | 2.9% |
| Telefonica S.A | 2.7% |
| ING Groep N.V. | 2.6% |
| Societe Generale | 2.5% |
| Daimler AG | 2.5% |
| Key | % Net Assets |
|---|---|
| 3.9% | |
| 3.4% | |
| 3.2% | |
| 3.2% | |
| 86.3% |
| Date | 13-Sep-2018 |
|---|---|
| NAV | 246.37p |
| Currency | GBP |
| Change | 0.000p |
| % | n/a |
| YTD change | 246.37p |
| YTD % | n/a |
| Fund Inception | 02/06/1986 |
|---|---|
| Fund Manager | John Botham |
| TER | 1.64 (15-Apr-2012) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.08 |
You are here: research